13F Pro quality score
Rank #2,688 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from OPKO HEALTH, INC.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $606.9M | $-225.7M | -19.4% |
| FY 2024 | 10-K | $713.1M | $-53.2M | -21.3% |
| FY 2023 | 10-K | $863.5M | $-188.9M | -18.2% |
| FY 2022 | 10-K | $1.0B | $-328.4M | -22.5% |
| FY 2021 | 10-K | $1.8B | $-30.1M | 1.1% |
| FY 2020 | 10-K | $1.4B | $30.6M | 4.0% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
OPKO HEALTH, INC. (OPK) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OPK at 23.3/100 on a composite quality score built from its SEC filings, placing it at rank #2,688 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (2.1) and revenue growth (9.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 41.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), OPKO HEALTH, INC. reports quarterly revenue of $163.6M, net income of $-8.4M, an operating margin of -4.3%. Top institutional holders of OPK by reported 13-F value include Rubric Capital Management, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. OPK trades on the Nasdaq exchange and files with the SEC under CIK 944809. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OPK daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OPKO HEALTH, INC. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 944809 →